Japanese Pharmacology & Therapeutics (JPT)
Vol. 41 Suppl. 2 2013
■ SYMPOSIUM
【Symposium 1 ：Quality of Life in Clinical Trials and Economic Evaluation】
Introduction
Quality of Life in Clinical Trials and Economic Evaluation
Y. Ohashi
Jpn Pharmacol Ther 2013 41(s2) s74-5
Health-Related Quality of Life Assessment in Clinical Trial
N. Taira
Jpn Pharmacol Ther 2013 41(s2) s76-8
Development Program for the Japanese Version of the PRO-CTCAE
T. Yamaguchi
Jpn Pharmacol Ther 2013 41(s2) s79-82
【Symposium 2 What the Monitoring for Clinical Trials in Japan should be.】
Current Status of Monitoring in Investigator-initiated Trials with IND
C. K. Imamura
Jpn Pharmacol Ther 2013 41(s2) s84-7
The Current Status of Monitoring for Industry-sponsored Clinical Trials and Investigator-initiated Clinical Trials in Japan
H.Oi
Jpn Pharmacol Ther 2013 41(s2) s88-91
■ORIGINAL ARTICLE
Association between Quality of Local Data Management and CRC Support / the Number of Registered Cases of an Investigator-initiated Clinical Trial
K. Murayama, et al.
Jpn Pharmacol Ther 2013 41(s2) s103-10
■CASE REPORT
A Proposal for Optimization of Clinical Trial by Central Monitoring System
－Consolidation by Applying the Operation Center and Electronic Data Sharing System －
Working Group 03 of the Monitoring 2.0 Group
M. Kitagawa, et al.
Jpn Pharmacol Ther 2013 41(s2) s111-20
Analysis of the Questions and Consultations Relevant to Clinical Studies in Osaka University Hospital
N. Yamamoto, et al.
Jpn Pharmacol Ther 2013 41(s2) s121-7
■REVIEW ARTICLE
Clinical Safety Data Management in Investigator-Initiated, Oncology Clinical Trials
T. Hata, et al.
Jpn Pharmacol Ther 2013 41(s2) s128-36